New

Create, analyze, optimize your ETF portfolio. Start now →

Advertisement
Advertisement

LABUvsETF 2ETF Comparison

ETF 1
LABU

Direxion Daily S&P Biotech Bull 3X Shares ETF - USD

This fund is part of
Leveraged Equity
+0%
VS
ETF 2

Choose a second ETF to run a side-by-side ETF comparison with LABU, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

LABU performance and flow charts

Performance

-20.0-15.0-10.0-5.00.0%Mar 2Mar 9Mar 16Mar 23Mar 30

Cumulative Flows

-80 M-60 M-40 M-20 M0 M20 M40 M60 MMar 2Mar 9Mar 16Mar 23Mar 30

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/02/2026
1M3MYTD1Y3Y5Y
Perf.
LABU
ETF 2
+1.29%
+8.85%
+7.65%
+191.18%
+71.36%
-89.63%
Flows
LABU
ETF 2
-$72M
-$342M
-$342M
-$960M
-$1.29B
+$763M
Volatility and drawdown
3M1Y3Y5Y
Volatility
LABU
ETF 2
+94.72%
+86.10%
+83.03%
+99.46%
Max drawdown
LABU
ETF 2
-30.65%
-36.75%
-78.32%
-97.75%
Max drawdown duration
LABU
ETF 2
70d
27d
661d
1800d
Trading data

Create an account to view trading data

Join for free
LABU
ETF 2
Last sale
4/2/2026 at 1:30 PM
$171.64
Previous close
04/02/2026
$169.63
Consolidated volume
04/02/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality

Replication data will be available soon

Advertisement
Main metrics
Last update 4/2/2026 at 1:30 PM
Live
Closed
LABU
ETF 2
Last price
$171.64
1D performance
+1.18%
AuM$458.37 M
E/R0.93%
Characteristics
LABU
ETF 2
Management strategyPassive
ProviderDirexion
BenchmarkS&P Biotechnology Select Industry Index
N° of holdings-
Asset classEquities
Trailing 12m distribution yield
Join
Join
Inception dateMay 28, 2015
ESGNo
Advertisement
Exposure

Exposure data will be available soon

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up